Reducing endothelial NOS activation and interstitial fluid pressure with n –3 PUFA offset tumor chemoresistance
Authors:
- Caroline GoupilleCGCaroline Goupille
- Sophie VibetSVSophie Vibet
- Stephan ChevalierSCStephan Chevalier
- Amandine PinetAPAmandine Pinet
- Justine LebeauJLJustine Lebeau
- François TranquartFTFrançois Tranquart
- Philippe BougnouxPBPhilippe Bougnoux
- Eric MartelEMEric Martel
- Anne MaurinAMAnne Maurin
- Serge RichardSRSerge Richard
- Pascal ChamperouxPCPascal Champeroux
- 23 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 33 (2) , 260-267
Abstract
The role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can enhance tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H, -R273H and -D281G showed enhanced migration, which was reversed by RNA interference (RNAi) or transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants, enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that GOF p53 proteins upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as CXCL5 and CXCL8 promoter activity was higher in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated histone H3 on the CXCL5 promoter in H1299/R273H cells, in agreement with increased transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also elevated in lung tumor samples containing GOF p53, indicating relevance to human cancer. The data suggest a mechanistic link between GOF p53 proteins and chemokines in enhanced cell motility.Keywords
This publication has 45 references indexed in Scilit:
- Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancerCancer, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Basal endothelial nitric oxide synthase (eNOS) phosphorylation on Ser1177 occurs in a stable microtubule- and tubulin acetylation-dependent mannerExperimental Cell Research, 2009
- Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trialBritish Journal of Cancer, 2009
- Antineoplastic Effects of N-3 Polyunsaturated Fatty Acids in Combination With Drugs and Radiotherapy: Preventive and Therapeutic StrategiesNutrition and Cancer, 2009
- Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical ImagingCancer Research, 2008
- Hydrogen sulfide downregulates the aortic l-arginine/nitric oxide pathway in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Compensatory Phosphorylation and Protein-Protein Interactions Revealed by Loss of Function and Gain of Function Mutants of Multiple Serine Phosphorylation Sites in Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2003
- Time‐course study of adipose tissue fatty acid composition during mammary tumor growth in rats with controlled fat intakeNutrition and Cancer, 1995